Explore more publications!
Anguilla Healthcare Digest
Got News to Share?

Anguilla Healthcare Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Anguilla Healthcare Digest.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on December 12, 2025

Alameda Health System reminds community: Apply for Medi-Cal before December 31, 2025
December 12, 2025

Alameda Health System reminds community: Apply for Medi-Cal before December 31, 2025

Indeterminate GlobeNewswire
Extendicare Announces December 2025 Dividend of C$0.042 per Share
December 12, 2025

Extendicare Announces December 2025 Dividend of C$0.042 per Share

Indeterminate GlobeNewswire
Teva Releases Q4 2025 Aide Memoire
December 12, 2025

Teva Releases Q4 2025 Aide Memoire

Indeterminate GlobeNewswire
Teva to Host Conference Call to Discuss Fourth Quarter 2025 Financial Results at 8 a.m. ET on January 28, 2026
December 12, 2025

Teva to Host Conference Call to Discuss Fourth Quarter 2025 Financial Results at 8 a.m. ET on January 28, 2026

Indeterminate GlobeNewswire
Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
December 12, 2025

Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Edesa Biotech Reports Fiscal Year 2025 Results
December 12, 2025

Edesa Biotech Reports Fiscal Year 2025 Results

Indeterminate GlobeNewswire
4DMT Announces New Employment Inducement Grants
December 12, 2025

4DMT Announces New Employment Inducement Grants

Indeterminate GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 12, 2025

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease
December 12, 2025

Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease

Indeterminate GlobeNewswire
CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 12, 2025

CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
GRI Bio Announces Closing of $8.0 Million Public Offering
December 12, 2025

GRI Bio Announces Closing of $8.0 Million Public Offering

Indeterminate GlobeNewswire
NurExone Plans Small-Scale of ExoPTEN Clinical Manufacturing in Preparation for FUTURE First in Human USE Pathways
December 12, 2025

NurExone Plans Small-Scale of ExoPTEN Clinical Manufacturing in Preparation for FUTURE First in Human USE Pathways

Indeterminate GlobeNewswire
Park Dental Partners Rings the Closing Bell on the Nasdaq in New York
December 12, 2025

Park Dental Partners Rings the Closing Bell on the Nasdaq in New York

Indeterminate GlobeNewswire
Tiziana Life Sciences to Dose First Patient in Phase 2 Alzheimer’s Trial
December 12, 2025

Tiziana Life Sciences to Dose First Patient in Phase 2 Alzheimer’s Trial

Indeterminate GlobeNewswire
Decking the Halls: 13th Annual Christmas Tree Giveaway Delivers Holiday Joy to More Than Families in Need
December 12, 2025

Decking the Halls: 13th Annual Christmas Tree Giveaway Delivers Holiday Joy to More Than Families in Need

Indeterminate GlobeNewswire
FDA Approves Amgen’s UPLIZNA® (inebilizumab-cdon) for Generalized Myasthenia Gravis (gMG), Expanding Treatment Options for Patients Living with Autoimmune Neuromuscular Disease
December 12, 2025

FDA Approves Amgen’s UPLIZNA® (inebilizumab-cdon) for Generalized Myasthenia Gravis (gMG), Expanding Treatment Options for Patients Living with Autoimmune Neuromuscular Disease

Indeterminate GlobeNewswire
Mineralys Therapeutics’ Phase 3 Launch-HTN Trial of Lorundrostat Recognized in Inaugural Journal of the American Medical Association (JAMA) “Research of the Year” Roundup
December 12, 2025

Mineralys Therapeutics’ Phase 3 Launch-HTN Trial of Lorundrostat Recognized in Inaugural Journal of the American Medical Association (JAMA) “Research of the Year” Roundup

Indeterminate GlobeNewswire
Lessing’s Hospitality Group Partners with Catholic Health to Launch Shoreline Café Across Long Island Hospitals
December 12, 2025

Lessing’s Hospitality Group Partners with Catholic Health to Launch Shoreline Café Across Long Island Hospitals

Indeterminate GlobeNewswire
Anavar Steroid 2026: Legal Steroid Alternative, Anavar For Women Cycle, Dosage, Side Effects, Anavar Before And After Result (Anavar for Sale) Launch Alternative Anvarol By CrazyBulk
December 12, 2025

Anavar Steroid 2026: Legal Steroid Alternative, Anavar For Women Cycle, Dosage, Side Effects, Anavar Before And After Result (Anavar for Sale) Launch Alternative Anvarol By CrazyBulk

Indeterminate GlobeNewswire
Cullgen Reports Positive Results from Phase 1 Study of its Novel Non-Opioid Product Candidate CG001419 for Pain
December 12, 2025

Cullgen Reports Positive Results from Phase 1 Study of its Novel Non-Opioid Product Candidate CG001419 for Pain

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions